Key Takeaways 9 major drugmakers agreed to lower U.S. drug prices to match comparable developed markets under MFN terms.Some drugmakers will donate key APIs to a federal stockpile to strengthen U.S. supply chain resilience.The Trump administration has now secured pricing deals with 14 of 17 targeted pharma companies.On Friday, President Trump announced that his administration has signed separate drug-pricing agreements with several large-cap drugmakers to lower drug prices in the country. These companies in ...